Clinical Study Demonstrates Viability of NeuraLight's Digital Biomarker Platform to Evaluate and Monitor Parkinson's Disease Progression webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.
Researchers assesses the effects of stimulation parameters suggested by a recently published data-driven algorithm (StimFit) based on neuroimaging data.
Denali Therapeutics is a great speculative biotech play to look into. This past year it has initiated two studies using a drug known as BIIB122. Click here to read more.
Annovis is targeting large market indications and the two of them are Alzheimer's and Parkinson's. See why I believe that ANVS is a great speculative biotech play.